MCI-225 is a selective NA reuptake inhibitor with 5-HT3 receptor antagonism. References: Schreiber S, Schreiber F, Lockhart SN, Horng A, Bejanin A, Landau SM, Jagust WJ; Alzheimer’s Disease Neuroimaging Initiative. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology. JAMA Neurol. 2017 Jun 1;74(6):650-659. doi: 10.1001/jamaneurol.2016.5349. PubMed PMID: 28319241; PubMed Central PMCID: PMC5822210.

纯度：≥98%

CAS：135991-48-9